HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.

导出 LinkOut

翻译打印收藏纠错

作者： Christin,Ackermann ^[1] ; Maike,Smits ^[2] ; Robin,Woost ^[3] ; Johanna M,Eberhard ^[1] ; Sven,Peine ^[4] ; Silke,Kummer ^[1] ; Matthias,Marget ^[4] ; Thomas,Kuntzen ^[5] ; William W,Kwok ^[1] ; Ansgar W,Lohse ^[4] ; Thomas,Jacobs ^[5] ; Tobias,Boettler ^[6] ; Julian,Schulze Zur Wiesch ^[7]

作者单位： I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[1] Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[2] Faculty of Biology, University of Freiburg, Freiburg, Germany. ^[3] DZIF partner site (German Center for Infection Research), Hamburg, Germany. ^[4] Department of Transfusion Medicine, Germany, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[5] Gastroenterologie und Hepatologie; Kantonsspital Aarau, Aarau, Switzerland. ^[6] Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America. ^[7] Protozoa Immunology, Bernhard Nocht, Institute for Tropical Medicine, Hamburg, Germany. ^[8] I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. julianszw@gmail.com. ^[9] DZIF partner site (German Center for Infection Research), Hamburg, Germany. julianszw@gmail.com. ^[10]